Turning Point Therapeutics is a clinical-stage precision oncology company with a pipeline of internally discovered investigational drugs designed to address key limitations of existing cancer therapies.
2024/3/28 10:43:18
(TPTX:NASDAQ)
Streetwise Reports Articles